PepGen Inc.
PEPGNASDAQHealthcare● Active
$1.35
$-0.00(-0.37%)
Market Cap$93032589
P/E Ratio—
52W High$7.8
52W Low$1.01
PepGen Inc. (PEPG) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
PEPG · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 12, 2026EPS Actual
-$0.26
Est. -$0.31 · +16.1%
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 12, 2026
After Market Close
▲ Beat EPS🔥 4-Quarter EPS Beat Streak
PEPG reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $6.21B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$6.21B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | -$0.30 | — | — | — | — | — |
| ▲ Q2 FY2026 | May 12, 2026 | -$0.31 | -$0.26 | +16.1% | — | — | — |
| ▲ Q1 FY2026 | Mar 4, 2026 | -$0.40 | -$0.27 | +32.5% | — | — | — |
| ▲ Q4 FY2025 | Nov 12, 2025 | -$0.63 | -$0.52 | +17.5% | — | — | — |
| ▲ Q3 FY2025 | Aug 7, 2025 | -$0.85 | -$0.70 | +17.6% | — | — | — |
| ▼ Q2 FY2025 | May 8, 2025 | -$0.72 | -$0.92 | -27.8% | — | — | — |
| ▲ Q1 FY2025 | Feb 24, 2025 | -$0.81 | -$0.68 | +16.1% | — | — | — |
| ▲ Q4 FY2024 | Nov 7, 2024 | -$0.87 | -$0.66 | +24.1% | — | — | — |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
-$0.30
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 12, 2026Beat
EPS Actual
-$0.26
EPS Est.
-$0.31
EPS Surpr.
+16.1%
Revenue
—
Q1 FY2026
Mar 4, 2026Beat
EPS Actual
-$0.27
EPS Est.
-$0.40
EPS Surpr.
+32.5%
Revenue
—
Q4 FY2025
Nov 12, 2025Beat
EPS Actual
-$0.52
EPS Est.
-$0.63
EPS Surpr.
+17.5%
Revenue
—
Q3 FY2025
Aug 7, 2025Beat
EPS Actual
-$0.70
EPS Est.
-$0.85
EPS Surpr.
+17.6%
Revenue
—
Q2 FY2025
May 8, 2025Miss
EPS Actual
-$0.92
EPS Est.
-$0.72
EPS Surpr.
-27.8%
Revenue
—
Q1 FY2025
Feb 24, 2025Beat
EPS Actual
-$0.68
EPS Est.
-$0.81
EPS Surpr.
+16.1%
Revenue
—
Q4 FY2024
Nov 7, 2024Beat
EPS Actual
-$0.66
EPS Est.
-$0.87
EPS Surpr.
+24.1%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.21 | $-0.21 | $-0.21 | 1 |
| Q3 FY2027 | $-0.21 | $-0.21 | $-0.21 | 1 |
| Q2 FY2027 | $-0.23 | $-0.23 | $-0.23 | 1 |
| Q1 FY2027 | $-0.23 | $-0.23 | $-0.23 | 1 |
| Q4 FY2026 | $-0.31 | $-0.31 | $-0.31 | 1 |
| Q3 FY2026 | $-0.39 | $-0.28 | $-0.23 | 5 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 12, 2026 | +16.1% | $1.70 | $1.68 | -1.18% |
| ▲ Q1 FY2026 | Mar 4, 2026 | +32.5% | $6.42 | $6.76 | +5.30% |
| ▲ Q4 FY2025 | Nov 12, 2025 | +17.5% | $4.65 | $5.13 | +10.32% |
| ▲ Q3 FY2025 | Aug 7, 2025 | +17.6% | $1.37 | $1.19 | -13.14% |
| ▼ Q2 FY2025 | May 8, 2025 | -27.8% | $1.26 | $1.54 | +22.22% |
| ▲ Q1 FY2025 | Feb 24, 2025 | +16.1% | $1.37 | $2.29 | +67.15% |
| ▲ Q4 FY2024 | Nov 7, 2024 | +24.1% | $7.19 | $5.63 | -21.70% |
| ▼ Q3 FY2024 | Aug 8, 2024 | -20.8% | $8.88 | $8.98 | +1.13% |
Q2 FY2026-1.18%
Report Date
May 12, 2026
EPS Beat/Miss
+16.1%
Price Before
$1.70
Price After
$1.68
Q1 FY2026+5.30%
Report Date
Mar 4, 2026
EPS Beat/Miss
+32.5%
Price Before
$6.42
Price After
$6.76
Q4 FY2025+10.32%
Report Date
Nov 12, 2025
EPS Beat/Miss
+17.5%
Price Before
$4.65
Price After
$5.13
Q3 FY2025-13.14%
Report Date
Aug 7, 2025
EPS Beat/Miss
+17.6%
Price Before
$1.37
Price After
$1.19
Q2 FY2025+22.22%
Report Date
May 8, 2025
EPS Beat/Miss
-27.8%
Price Before
$1.26
Price After
$1.54
Q1 FY2025+67.15%
Report Date
Feb 24, 2025
EPS Beat/Miss
+16.1%
Price Before
$1.37
Price After
$2.29
Q4 FY2024-21.70%
Report Date
Nov 7, 2024
EPS Beat/Miss
+24.1%
Price Before
$7.19
Price After
$5.63
Q3 FY2024+1.13%
Report Date
Aug 8, 2024
EPS Beat/Miss
-20.8%
Price Before
$8.88
Price After
$8.98
Avg Beat Reaction+7.79%
Avg Miss Reaction+11.67%
Beat Rate6 / 8 quarters
Largest Move+67.15% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: PEPG ends December
PepGen Inc. (PEPG) most recently reported earnings on May 12, 2026 for Q2 FY2026, posting EPS of $-0.26 — beating the analyst consensus of $-0.31 by +16.1%. PEPG has beaten EPS estimates for 4 consecutive quarters. The next PEPG earnings date is expected around September 1, 2026.
Each quarter, investors track PEPG earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. PEPG revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
PEPG's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
PEPG earnings · 5 questionsPepGen Inc.'s next earnings report is expected around September 1, 2026. PEPG typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; PEPG historically reports after market close (AMC).
PEPG earnings datewhen is PEPG earningsPEPG next earnings datewhen does PEPG report earningsPEPG earnings calendar
▸ Source: FMP · PepGen Inc. SEC filings · US GAAP · PepGen Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026